ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

New CCOP RFA Available; Briefing At ASCO Jammed

June 2, 1989

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

November 18, 2011

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

April 6, 1979

NCI Advisors Approve Continuation Of Cancer Genome Atlas Network.

December 19, 2008

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995